Citigroup
IGC icon

Citigroup’s IGC Pharma IGC Stock Holding History

Citigroup’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,000
Closed -$19K – 7738
2018
Q3 		$19K Buy
+3,000
New +$3.12K ﹤0.01% 7106

Other funds holding IGC

CFA
Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return

Citigroup's IGC Position: Q4 2018 in Review

Citigroup sold out of IGC Pharma (IGC) in Q4 2018, closing a stake of 3,000 shares — an estimated $19K sold.

Citigroup first reported a position in IGC in Q3 2018 and held it in 1 quarter. The position peaked at $19K in Q3 2018. 4 funds tracked by Wall St. Rank hold IGC as of Q4 2018.

  • Citigroup reported no remaining IGC Pharma position as of Q4 2018 after selling out during the quarter.
  • Citigroup sold 3,000 IGC Pharma shares in Q4 2018, an estimated $19K.
  • Citigroup first reported a position in IGC Pharma in Q3 2018 and held it in 1 quarter.
  • Citigroup's IGC Pharma position peaked at $19K in Q3 2018.
  • 4 funds tracked by Wall St. Rank held IGC Pharma as of Q4 2018.

Based on Citigroup's 13F filing for Q4 2018, filed 12 Feb 2019.